Cumberland Biotherapeutics Announces U.S. Launch of FDA Cleared DentoClude F, Complimentary Practice Program, and New Investor Fundraising Initiative
Cumberland Biotherapeutics, LLC, a dental innovation company integrating advanced bioactive glass with botanicals, today announced the U.S. launch of DentoClude F; DentoClude F is marketed under a commercial name for the Occlude® F Dentin Tubule Agent, which received FDA 510(k) clearance under... - December 30, 2025
Press Releases 1 - 1 of 1